Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS
Summary
The Bonds will be callable by the Company, at par value, at quarterly intervals, the first time on 30 June 2026.For further information, please contact: Jon Olav \xd8deg\xe5rd, CEO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: joo@hofsethbiocare.noHofseth BioCare is a Norwegian consumer and pet health company founded on the core values of sustainability, optimal utilization of natural resources and full traceability. These ingredients are ProGo\xae, a mix of bioactive peptides and collagen, OmeGo\xae, a whole salmon oil, with all the fatty acid fractions contained in fish, and CalGo\xae / NT-II((TM)) salmon bone powder containing calcium hydroxyapatite and undenatured collagen for bone and joint health. HBC places scientific evidence at the forefront which has led to important academic partnerships and the identification of unique health benefits. This includes the demonstration of improved iron metabolism by boosting the bodys ability to take up and use iron resulting in increased energy and vitality with ProGo\xae as well as the activation of the GLP-1 receptor with fat reduction in overweight adults. Finally, CalGo\xae has shown both bone and joint health benefits to support healthy ageing and active lifestyles.